<DOC>
	<DOCNO>NCT00104676</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . PURPOSE : This randomized phase III trial compare two different combination chemotherapy regimens see well work treat patient stage II stage III non-seminomatous germ cell tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Stage II Stage III Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Compare progression-free survival rate patient poor prognosis stage II III non-seminomatous germ cell tumor unfavorable decrease tumor marker treatment 1 course bleomycin , etoposide , cisplatin follow subsequent treatment 3 additional course bleomycin , etoposide , cisplatin OR dose-dense sequential combination chemotherapy . - Compare overall survival patient treat regimen . OUTLINE : This randomize , multicenter study . Patients receive 1 course bleomycin , etoposide , cisplatin ( BEP ) . Patients favorable decrease tumor marker 1 course BEP receive 3 additional course BEP . Patients unfavorable decrease tumor marker 1 course BEP randomize 1 2 treatment arm . - Arm I : Patients receive 3 additional course BEP . - Arm II : Patients receive dose-dense sequential combination chemotherapy comprise cisplatin , etoposide , bleomycin , paclitaxel , oxaliplatin , ifosfamide . PROJECTED ACCRUAL : A total 260 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonseminomatous germ cell tumor ( NSGCT ) evidence 1 follow criterion : Histologically confirm NSGCT Clinical evidence disease AND high serum human chorionic gonadotropin ( HCG ) alphafetoprotein ( AFP ) level Clinical stage IIIII disease ( disseminated disease ) Testicular , retroperitoneal , mediastinal primary site Poor prognosis disease , meet 1 follow criterion : Mediastinal primary site Nonpulmonary visceral metastasis One follow lab value : HCG &gt; 50,000 UI/L AFP &gt; 10,000 ng/mL Lactate dehydrogenase &gt; 10 time upper limit normal ( ULN ) PATIENT CHARACTERISTICS : Age Over 16 Performance status Not specify Life expectancy Not specify Hematopoietic Absolute granulocyte count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic Bilirubin ≤ 1.5 time ULN Renal Creatinine clearance &gt; 60 mL/min Other No prior malignancy except basal cell skin cancer No HIV positivity PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>stage II malignant testicular germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>stage II extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage III extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>testicular immature teratoma</keyword>
	<keyword>testicular mature teratoma</keyword>
	<keyword>adult teratoma</keyword>
</DOC>